4//SEC Filing
ZDRAVESKI ZORAN 4
Accession 0000950170-25-018131
CIK 0001783328other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:54 PM ET
Size
7.7 KB
Accession
0000950170-25-018131
Insider Transaction Report
Form 4
ZDRAVESKI ZORAN
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2025-01-03+250,000→ 250,000 totalExercise: $3.06Exp: 2035-01-03→ Voting Common Stock (250,000 underlying) - Award
Stock Option (Right to Buy)
2024-01-12+52,500→ 52,500 totalExercise: $6.00Exp: 2034-01-12→ Voting Common Stock (52,500 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 12, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.
- [F2]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.
Documents
Issuer
TScan Therapeutics, Inc.
CIK 0001783328
Entity typeother
Related Parties
1- filerCIK 0001741285
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 5:54 PM ET
- Size
- 7.7 KB